Holen Sie sich die Stockscreener-App
1.56
1.27%
-0.02
Handel nachbörslich:
1.58
0.02
+1.28%
Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology - TipRanks
PMV Pharmaceuticals (NASDAQ:PMVP) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Trend Recap: Does TriNet Group Inc have pricing powerEarnings Overview Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
Risk On: Whats the outlook for PMV Pharmaceuticals Incs sectorWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
PMVP Reports Positive Phase 2 Results, Eyes 2027 NDA Submission - GuruFocus
PMV Pharma (PMVP) Reports Decline in Cash Reserves by Year-End 2 - GuruFocus
PMV Pharmaceuticals Reports Progress in PYNNACLE Trial of Rezatapopt for Ovarian Cancer and Announces Orphan Drug Designation from FDA - Quiver Quantitative
PMV Pharmaceuticals 10-K: Revenue $0, EPS $(1.48) — FY2025 results - TradingView
PMVP: Net loss widened to $77.7M as rezatapopt advanced in trials; cash runway extends to Q2 2027 - TradingView
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights - Yahoo Finance
PMVP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Short Interest Update - MarketBeat
PMV Pharmaceuticals Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Health Rounds: Researchers find cellular clues to explain faster pain recovery in men - marketscreener.com
PMV Pharma’s rezatapopt study published in New England Journal - Investing.com Australia
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
PMV Pharmaceuticals (PMVP) Publishes Positive Phase 1 Results fo - GuruFocus
PMV Pharma’s rezatapopt study published in New England Journal By Investing.com - Investing.com UK
New England Journal of Medicine Publishes First-in-Human - GlobeNewswire
Risk Analysis: Is PMV Pharmaceuticals Inc benefiting from interest rate changes2025 Biggest Moves & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
PMV Pharmaceuticals (PMVP) to Release Quarterly Earnings on Monday - Defense World
Avadel Pharmaceuticals (AVDL) to Release Earnings on Monday - Defense World
Decliners Report: Can NSYS lead its sector in growthTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Signal Recap: How much upside does LNKB haveJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Dow Update: Is Oxbridge Re Holdings Limited benefiting from interest rate changes2025 Geopolitical Influence & Short-Term High Return Ideas - baoquankhu1.vn
Growth Review: Is Accretion Acquisition Corp Equity Right stock risky to hold nowMarket Activity Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Will PMV Pharmaceuticals Inc outperform its industry peersJuly 2025 WrapUp & Weekly Market Pulse Alerts - baoquankhu1.vn
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 0.9%Time to Buy? - MarketBeat
Fund Flows: Whats the RSI of PMV Pharmaceuticals Inc stockMarket Sentiment Report & Fast Gaining Stock Reports - baoquankhu1.vn
Why Columbus Acquisition Corp stock is a value investor pickRate Cut & Weekly Watchlist of Top Performers - mfd.ru
Will NDLS stock deliver better than expected guidanceWeekly Trend Report & Weekly Stock Breakout Alerts - mfd.ru
PMVP PE Ratio & Valuation, Is PMVP Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and OrganiGram Holdings (OGI) - The Globe and Mail
Guidance Update: Is PMV Pharmaceuticals Incs ROE strong enoughJuly 2025 PreEarnings & Weekly Stock Breakout Alerts - baoquankhu1.vn
Fed Watch: Will PMV Pharmaceuticals Inc outperform its industry peersAnalyst Upgrade & AI Powered Market Entry Strategies - baoquankhu1.vn
PMV Pharmaceuticals: Key Catalysts Approach in Q1 2026 - AD HOC NEWS
Tech Rally: Whats the RSI of PMV Pharmaceuticals Inc stockMarket Volume Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Support Test: Whats the outlook for PMV Pharmaceuticals Incs sectorProduct Launch & Detailed Earnings Play Alerts - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Xeris Pharmaceuticals (XERS) - The Globe and Mail
Caesarstone And 2 More Penny Stocks Worth Watching - simplywall.st
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 3.4%Here's Why - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 3.4% – Here’s Why - Defense World
Will PMV Pharmaceuticals (NASDAQ:PMVP) Spend Its Cash Wisely? - simplywall.st
Weekly Earnings: Can MTRX generate free cash flowQuarterly Trade Summary & Safe Entry Zone Identification - baoquankhu1.vn
Stock Market Recap: Does LEGTWS have strong EBITDA marginsBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
Options Flow: Will Ford Motor Company outperform tech stocksGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
MBX Biosciences appoints Laurie Stelzer to board of directors By Investing.com - Investing.com Nigeria
MBX Biosciences appoints Laurie Stelzer to board of directors - Investing.com
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair - The Manila Times
Laurie Stelzer, ex-CFO at Mirati and Arena, joins MBX board - Stock Titan
Aug EndMonth: Will IMXI benefit from green energy policies2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Stock Recap: Is PMV Pharmaceuticals Inc a strong candidate for buy and hold2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Take Profit: How does OPRT correlate with NasdaqJuly 2025 Catalysts & Accurate Intraday Trade Tips - baoquankhu1.vn
How FLYX.W stock compares with market leadersMarket Performance Summary & Stepwise Swing Trade Plans - bollywoodhelpline.com
Why analysts upgrade PMV Pharmaceuticals Inc. stockJuly 2025 Trends & Long-Term Growth Stock Strategies - bollywoodhelpline.com
Will PMV Pharmaceuticals Inc. outperform its industry peersJuly 2025 Volume & Low Drawdown Investment Strategies - bollywoodhelpline.com
Trading Recap: Can VALWS stock outperform in a bear marketJuly 2025 Technicals & Technical Buy Zone Confirmation - baoquankhu1.vn
Fed Watch: Can PMV Pharmaceuticals Inc grow without external funding2025 Sector Review & Reliable Price Breakout Signals - baoquankhu1.vn
Growth Report: Can PMV Pharmaceuticals Inc. stock double in next 5 yearsWeekly Investment Report & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Fed Meeting: How PMV Pharmaceuticals Inc stock reacts to oil pricesJuly 2025 Summary & Risk Managed Trade Strategies - Bộ Nội Vụ
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - Nature
Can Cranex Limited Overcome Bearish SentimentMarket Profile Overview & Big Profit Small Budget - bollywoodhelpline.com
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):